Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area, Supporting the "Healthy China" Initiative

MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping

NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine

Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach

Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients

Key Resources and Organizations for Precision Medicine Guidelines

MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine

NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment

Home
/
update
/
details

Hamad Medical Corporation Hosts 3rd Precision Medicine Conference on AI and Genomics Integration

NextEdge Admin

07 Nov 2024

2 min 1 sec

Hamad Medical Corporation (HMC) recently held its 3rd HMC Precision Medicine Conference, focusing on “Shaping the Future Through Integration: Exploring the Latest Technologies and AI Applications.” The event brought together over 900 healthcare professionals and researchers to discuss how collaboration, AI, and innovation are driving advancements in precision medicine.

The conference highlighted the transformative potential of AI and genomics in personalizing healthcare. Dr. Abdulla al-Ansari, HMC’s chief medical officer and chair of the Precision Medicine Committee, called the event a significant step toward integrating advanced technologies into clinical practice. “This conference represented a great step forward in our mission to integrate advanced technologies and artificial intelligence into clinical practice,” he noted.

Dr. Salha Bujassoum al-Bader, director of the Centre for Clinical Precision Medicine and Genomics, emphasized the importance of knowledge sharing to enhance patient outcomes in Qatar and beyond. “Incorporating the latest technologies and artificial intelligence into our practices is essential to providing personalized care that meets the unique needs of our patients,” she said.

The conference underscored both the promise and challenges of implementing precision medicine in everyday practice. Dr. al-Ansari highlighted the role of partnerships in optimizing personalized patient care, aiming to overcome barriers to integrating precision medicine across healthcare settings.